Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 275

Similar articles for PubMed (Select 23916692)

1.

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.

Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, Vermathen P, Fleischmann A, Thoeny HC.

Eur Urol. 2013 Dec;64(6):953-60. doi: 10.1016/j.eururo.2013.07.032. Epub 2013 Jul 30.

PMID:
23916692
2.
3.

Clinical significance of three-dimensional measurement of tumour thickness on magnetic resonance imaging in patients with oral tongue squamous cell carcinoma.

Kwon M, Moon H, Nam SY, Lee JH, Kim JW, Lee YS, Roh JL, Choi SH, Kim SY.

Eur Radiol. 2015 Jun 25. [Epub ahead of print]

PMID:
26108641
4.

A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.

Turkbey B, Agarwal HK, Shih J, Bernardo M, McKinney YL, Daar D, Griffiths GL, Sankineni S, Johnson L, Grant KB, Weaver J, Rais-Bahrami S, Harisinghani M, Jacobs P, Dahut W, Merino MJ, Pinto PA, Choyke PL.

AJR Am J Roentgenol. 2015 Jul;205(1):64-9. doi: 10.2214/AJR.14.13009.

PMID:
26102381
5.

Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.

Li T, Gendelman HE, Zhang G, Puligujja P, McMillan JM, Bronich TK, Edagwa B, Liu XM, Boska MD.

Int J Nanomedicine. 2015 Jun 3;10:3779-90. doi: 10.2147/IJN.S83279. eCollection 2015.

6.

Effect of parallel radiofrequency transmission on arterial input function selection in dynamic contrast-enhanced 3 Tesla pelvic MRI.

Chafi H, Elias SN, Nguyen HT, Friel HT, Knopp MV, Guo B, Heymsfield SB, Jia G.

J Magn Reson Imaging. 2015 Jun 9. doi: 10.1002/jmri.24969. [Epub ahead of print]

PMID:
26069205
7.

Bladder cancer: Dorsolateral peritoneal layer adaptation following PLND.

[No authors listed]

Nat Rev Urol. 2015 May 26. doi: 10.1038/nrurol.2015.128. [Epub ahead of print] No abstract available.

PMID:
26032548
8.

Diffusion MRI on lymph node staging of gastric adenocarcinoma.

Hasbahceci M, Akcakaya A, Memmi N, Turkmen I, Cipe G, Yildiz P, Arici DS, Muslumanoglu M.

Quant Imaging Med Surg. 2015 Jun;5(3):392-400. doi: 10.3978/j.issn.2223-4292.2015.03.06.

9.

Whole body diffusion weighted MRI - a new view of myeloma.

Messiou C, Kaiser M.

Br J Haematol. 2015 May 26. doi: 10.1111/bjh.13509. [Epub ahead of print]

PMID:
26013304
10.

Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates.

Sankineni S, Smedley J, Bernardo M, Brown AM, Johnson L, Muller B, Griffiths GL, Kobayashi H, Rais-Bahrami S, Pinto PA, Wood BJ, Keele B, Choyke PL, Turkbey B.

Acta Radiol. 2015 May 26. pii: 0284185115586023. [Epub ahead of print]

PMID:
26013022
11.

Theranostic Photosensitive Nanoparticles for Lymph Node Metastasis of Gastric Cancer.

Tsujimoto H, Morimoto Y, Takahata R, Nomura S, Yoshida K, Hiraki S, Horiguchi H, Miyazaki H, Ono S, Saito D, Hara I, Ozeki E, Yamamoto J, Hase K.

Ann Surg Oncol. 2015 May 19. [Epub ahead of print]

PMID:
25986868
12.
13.

Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer.

Tarabichi M, Saiselet M, Trésallet C, Hoang C, Larsimont D, Andry G, Maenhaut C, Detours V.

Br J Cancer. 2015 May 12;112(10):1665-74. doi: 10.1038/bjc.2014.665.

PMID:
25965298
14.

Nanoparticle enhanced MRI scanning to detect cellular inflammation in experimental chronic renal allograft rejection.

Alam SR, Tse GH, Stirrat C, MacGillivray TJ, Lennen RJ, Jansen MA, Newby DE, Marson L, Henriksen PA.

Int J Mol Imaging. 2015;2015:507909. doi: 10.1155/2015/507909. Epub 2015 Apr 14.

15.

Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study.

De Bari B, Vallati M, Gatta R, Simeone C, Girelli G, Ricardi U, Meattini I, Gabriele P, Bellavita R, Krengli M, Cafaro I, Cagna E, Bunkheila F, Borghesi S, Signor M, Di Marco A, Bertoni F, Stefanacci M, Pasinetti N, Buglione M, Magrini SM.

Cancer Invest. 2015 Jul;33(6):232-40. doi: 10.3109/07357907.2015.1024317. Epub 2015 May 7.

PMID:
25950849
16.

Prostate cancer: Can imaging accurately diagnose lymph node involvement?

Barentsz JO, Thoeny HC.

Nat Rev Urol. 2015 Jun;12(6):313-5. doi: 10.1038/nrurol.2015.91. Epub 2015 May 5. No abstract available.

PMID:
25941790
17.

Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice.

Andreou A, Sohaib A, Collins DJ, Takahara T, Kwee TC, Leach MO, MacVicar DA, Koh DM.

Cancer Imaging. 2015 May 2;15:6. doi: 10.1186/s40644-015-0041-5.

18.

Characteristics of undetected prostate cancer on diffusion-weighted MR Imaging at 3-Tesla with a b-value of 2000s/mm2: Imaging-pathologic correlation.

Barral M, Cornud F, Neuzillet Y, Lonchampt E, Lassalle L, Delonchamp NB, Scherrer A.

Diagn Interv Imaging. 2015 Apr 28. pii: S2211-5684(15)00128-X. doi: 10.1016/j.diii.2015.03.004. [Epub ahead of print]

PMID:
25934182
19.

Nanotechnology in bladder cancer: current state of development and clinical practice.

Tomlinson B, Lin TY, Dall'Era M, Pan CX.

Nanomedicine (Lond). 2015;10(7):1189-201. doi: 10.2217/nnm.14.212.

PMID:
25929573
20.

A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer.

Bollineni VR, Kramer G, Liu Y, Melidis C, deSouza NM.

Cancer Treat Rev. 2015 Jun;41(6):496-502. doi: 10.1016/j.ctrv.2015.03.010. Epub 2015 Apr 11. Review.

PMID:
25892290
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk